Form 4: Viemed Healthcare CFO Trae Fitzgerald Reports Stock Transactions

Viemed Healthcare's Chief Financial Officer, Trae Fitzgerald, reported the vesting of restricted stock units and phantom share units, along with associated tax withholdings, on January 29, 2025.

Summary

• Trae Fitzgerald, the Chief Financial Officer of Viemed Healthcare, reported several transactions involving the company's stock on January 29, 2025.
• These transactions include the vesting of 9,795 restricted stock units (RSUs) and 3,265 phantom share units.
• A total of 2,962 shares were withheld to cover tax obligations related to the vesting of the RSUs.
• The vesting of the phantom share units resulted in the acquisition of 3,265 common shares and a simultaneous disposition of the same number of shares for cash.
• The price per share for the tax withholding and phantom share settlement was $8.28, based on the market closing price on January 29, 2025.
• Following these transactions, Mr. Fitzgerald directly owns 82,994 common shares.

Sentiment

Score: 7

Explanation: The document reflects routine executive compensation activity, which is neither positive nor negative. It is a neutral event from an investment perspective.

Industry Context

This is a routine filing related to executive compensation and is common for publicly traded companies. It provides transparency into the stock transactions of key personnel.

Comparison to Industry Standards

• Stock-based compensation is a common practice across the healthcare industry, particularly for executive roles.
• The vesting schedules and types of equity awards (RSUs and phantom shares) are typical for companies of Viemed's size and stage.
• Similar filings are regularly made by executives at comparable companies such as AdaptHealth Corp and Rotech Healthcare Inc.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they relate to executive compensation.
• The tax withholding reduces the number of shares held by the executive, which is a standard practice.

Key Dates

Keywords

Viemed Healthcare, stock transactions, restricted stock units, phantom share units, insider trading, Form 4, Trae Fitzgerald, executive compensation